Skip to main content

Alessandra NARDIN

Dr. Alessandra NARDINAlessandra NARDIN
Vice President (Strategy)
ImmunoScape, Singapore
Dr. Alessandra NARDINAlessandra NARDIN
Vice President (Strategy)
ImmunoScape, Singapore

Biosketch

Dr Alessandra Nardin is Co-founder, Board Director, and VP, Strategy at ImmunoScape, a Singapore and US-based biotechnology company that discovers and develops TCR-based therapeutics against solid tumors, by leveraging its deep immunomics and machine learning platforms.

With a clinical background in Veterinary Medicine, Dr Nardin has worked in both academic and biotech environments across Italy, US, France and Singapore. Her research experience spans a broad range of translational immunology and immunotherapy areas, including antibody-based therapeutics against infectious diseases and cancer (University of Virginia), immune cell biology, tumor microenvironment, cancer vaccines and cell therapy strategies (IDM Biotech and A*STAR). She led both scientific and business development, IP and project management teams.

She co-founded ImmunoScape in 2017 and served as COO until 2022.